These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 33413406

  • 21. Genetics of canine myxomatous mitral valve disease.
    O'Brien MJ, Beijerink NJ, Wade CM.
    Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
    [Abstract] [Full Text] [Related]

  • 22. Iron parameters analysis in dogs with myxomatous mitral valve disease.
    Kumiega E, A Kobak K, Noszczyk-Nowak A, Kasztura M.
    BMC Vet Res; 2024 May 18; 20(1):210. PubMed ID: 38762716
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
    Zhou Q, Wu Z, Li L, Zhou H, Chen Y, Guo S, Guo Y, Ma X, Zhang J, Feng W, Cui X, Qiu C, Xu M, Deng G.
    J Proteomics; 2023 Jun 30; 282():104924. PubMed ID: 37146676
    [Abstract] [Full Text] [Related]

  • 25. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I, Höglund K, Lilliehöök I, Oyama MA, Tidholm A, Tvedten H, Häggström J.
    J Vet Intern Med; 2013 Jun 30; 27(5):1105-12. PubMed ID: 23865457
    [Abstract] [Full Text] [Related]

  • 26. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK, Atkins CE, Lee S, Lantis AC, zumBrunnen JR.
    Am J Vet Res; 2015 Dec 30; 76(12):1041-50. PubMed ID: 26618728
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Bernay F, Bland JM, Häggström J, Baduel L, Combes B, Lopez A, Kaltsatos V.
    J Vet Intern Med; 2010 Dec 30; 24(2):331-41. PubMed ID: 20102506
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL.
    J Vet Intern Med; 2024 Dec 30; 38(1):51-60. PubMed ID: 37909399
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM.
    Am J Vet Res; 2017 Apr 30; 78(4):440-446. PubMed ID: 28345991
    [Abstract] [Full Text] [Related]

  • 31. Aldosterone-progesterone relationship in sexually intact Chihuahua bitches.
    Galizzi A, Dossi G, Borromeo V, Pocar P, Groppetti D, Locatelli C.
    BMC Vet Res; 2023 Sep 05; 19(1):144. PubMed ID: 37670293
    [Abstract] [Full Text] [Related]

  • 32. Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease.
    Sabetti MC, Fidanzio F, Troìa R, Perissinotto L, Romito G, Mazzoldi C, Quintavalla C, Crosara S, Dondi F.
    J Vet Cardiol; 2022 Jun 05; 41():57-69. PubMed ID: 35245876
    [Abstract] [Full Text] [Related]

  • 33. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Cremer SE, Kristensen AT, Reimann MJ, Eriksen NB, Petersen SF, Marschner CB, Tarnow I, Oyama MA, Olsen LH.
    Am J Vet Res; 2015 Jun 05; 76(6):520-31. PubMed ID: 26000599
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
    Reimann MJ, Häggström J, Møller JE, Lykkesfeldt J, Falk T, Olsen LH.
    J Vet Intern Med; 2017 Mar 05; 31(2):295-302. PubMed ID: 28132441
    [Abstract] [Full Text] [Related]

  • 36. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE, Singletary GE, Olsen LH, Wallace K, Häggström J, Ljungvall I, Höglund K, Reynolds CA, Pizzinat N, Oyama MA.
    J Vet Intern Med; 2014 Mar 05; 28(5):1534-40. PubMed ID: 25146933
    [Abstract] [Full Text] [Related]

  • 37. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
    Bach MBT, Stougaard CL, Thøfner MS, Reimann MJ, Westrup U, Koch J, Fredholm M, Martinussen T, Berendt M, Olsen LH.
    J Vet Intern Med; 2024 Mar 05; 38(2):904-912. PubMed ID: 38391152
    [Abstract] [Full Text] [Related]

  • 38. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
    Wesselowski S, Gordon SG, Fries R, Saunders AB, Sykes KT, Vitt J, Boutet B, Häggström J, Kadotani S, Stack J, Barnett BG.
    J Vet Cardiol; 2023 Dec 05; 50():1-16. PubMed ID: 37913604
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.